Ionis Pharmaceuticals IONS Increase (Decrease) in Inventories
Increase (Decrease) in Inventories at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's increase (decrease) in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's increase (decrease) in inventories?
- Ionis Pharmaceuticals (IONS) reported increase (decrease) in inventories of -$338K in Q1 2026.
- How has Ionis Pharmaceuticals's increase (decrease) in inventories changed year-over-year?
- Ionis Pharmaceuticals's increase (decrease) in inventories increased by 66.5% year-over-year, from -$1.01M to -$338K.
- What is the long-term trend for Ionis Pharmaceuticals's increase (decrease) in inventories?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's increase (decrease) in inventories has grown at a 143.2% compound annual growth rate (CAGR), from $2.47M to $14.6M.
- What does increase (decrease) in inventories mean?
- The net change in the value of the company's stock of goods and materials.
- How do you interpret increase (decrease) in inventories?
- An increase can signal preparation for sales growth, while a decrease may indicate efficient inventory turnover or reduced production needs.
- How does increase (decrease) in inventories compare across companies?
- Standard metric across all manufacturing and life sciences companies.